市場調查報告書
商品編碼
843127

益智劑的全球市場:產業展望,綜合分析,未來預測

Nootropics Market By Application (Memory Enhancement, Mood and Depression, Attention and Focus, Longevity and Anti-Aging, Sleep, Recovery, and Dream Enhancement, and Anxiety): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017-2024

出版日期: | 出版商: Zion Market Research | 英文 110 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球益智劑的市場相關分析,市場基本結構和趨勢預測 (過去3年、今後7年份),各用途、各地區的詳細趨勢,市場競爭環境 (市場佔有率結構,主要的資本交易趨勢等),主要企業的概要、業績、戰略構想等調查。

第1章 序論

第2章 摘要整理

第3章 益智劑市場:產業分析

  • 簡介
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 波特的五力分析
  • 市場向心力分析:各用途、各地區

第4章 全球益智劑市場:競爭環境

  • 各企業市場佔有率分析
  • 策略展開情形
    • 企業合併、收購 (M&A)
    • 新產品的銷售
    • 事業聯盟、合作,協定,合資企業
    • 研究開發 (R&D),海外發展
  • 產品系列

第5章 全球益智劑市場:各用途的市場分析

  • 全球益智劑市場:各用途概況
    • 市場佔有率:各用途 (最新值、預測值)
  • 記憶力強化
  • 心理障礙、憂鬱症
  • 注意力、注意力強化
  • 長壽、抗老化
  • 睡眠改善、疲勞復甦
  • 焦慮症
    • 市場規模 (以金額為準,總計10年份)

第6章 全球益智劑市場:各地區的市場分析

  • 全球益智劑市場:各地區的概況
    • 市場佔有率:各地區 (最新值、預測值)
  • 北美市場 (美國等)
    • 市場規模:各用途 (以數量、金額為準,總計10年份)
    • 各國分析
  • 歐洲市場 (英國,法國,德國等)
  • 亞太地區市場 (中國,日本,印度等)
  • 南美市場 (巴西等)
  • 中東、非洲市場

第7章 全球益智劑市場:企業簡介

  • Accelerated Intelligence, Inc.
    • 概要
    • 財務分析
    • 產品系列
    • 事業策略
    • 目前的趨勢
  • Nootrobox, Inc.
  • AlternaScript LLC
  • Onnit Labs LLC
  • Cephalon, Inc.
  • Clarity Nootropics
  • Peak Nootropics
  • United Pharmacies
  • Powder City LLC
  • Purelife Bioscience Co., Ltd.
  • SupNootropic Biological Technology Co., Ltd.
目錄

The report covers a forecast and an analysis of the nootropics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints of the nootropics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and threats to the nootropics market on a global level.

To understand the competitive landscape in the market, an analysis of Porters Five Forces model for the nootropics market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the nootropics market by segmenting the market based on application and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on application, the nootropics market is segmented into memory enhancement, mood and depression, attention and focus, longevity and anti-aging, sleep, recovery and dream enhancement, and anxiety. The regional segmentation includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

The report includes detailed profiles of the key players in the nootropics market globally, such as Accelerated Intelligence, Inc., Nootrobox, Inc., AlternaScript LLC, Onnit Labs LLC, Cephalon, Inc., Clarity Nootropics, Peak Nootropics, United Pharmacies, Powder City LLC, Purelife Bioscience Co., Ltd, and SupNootropic Biological Technology Co., Ltd., among others.

This report segments the global nootropics market into:

Global Nootropics Market: Application Analysis

  • Memory Enhancement
  • Mood and Depression
  • Attention and Focus
  • Longevity and Anti-aging
  • Sleep, Recovery and Dream Enhancement
  • Anxiety

Global Nootropics Market: Regional Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa

Table Of Contents

Chapter 1. Introduction

  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

Chapter 2. Executive Summary

  • 2.1. Global Nootropics Market, 2015 - 2024(USD Million)
  • 2.2. Global Nootropics Market: Snapshot

Chapter 3. Nootropics Market - Industry Dynamics

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global Nootropics Market Drivers: Impact Analysis
    • 3.2.2. Growing Awareness Regarding Health Benefits of the Nootropics
  • 3.3. Market Restraints
    • 3.3.1. Global Nootropics Market Restraints: Impact Analysis
    • 3.3.2. The high cost of products
  • 3.4. Opportunities
    • 3.4.1. Growing vegan population
    • 3.4.2. Increasing Investment by the Market players
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market Attractiveness Analysis, by Application
    • 3.6.2. Market Attractiveness Analysis, by Region

Chapter 4. Global Nootropics Market - Competitive Landscape

  • 4.1. Company Market Share, 2017 (Subject To Data Availability)
    • 4.1.1. Global Nootropics Market: Company Market Share, 2017
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
    • 4.2.4. Research and Development and Regional Expansion
  • 4.3. Product Portfolio

Chapter 5. Global Nootropics Market - Application Analysis

  • 5.1. Global Nootropics Market: Application Overview
    • 5.1.1. Global Nootropics Market Revenue Share, by Application, 2017 -2024
  • 5.2. Memory Enhancement
    • 5.2.1. Global Nootropics Market for Memory Enhancement, 2015 - 2024 (USD Million)
  • 5.3. Mood and Depression
    • 5.3.1. Global Nootropics Market for Mood and Depression, 2015 - 2024 (USD Million)
  • 5.4. Attention and Focus
    • 5.4.1. Global Nootropics Market for Attention and Focus, 2015 - 2024 (USD Million)
  • 5.5. Longevity and Anti-aging
    • 5.5.1. Global Nootropics Market for Longevity and Anti-aging, 2015 - 2024 (USD Million)
  • 5.6. Sleep, Recovery and Dream Enhancement
    • 5.6.1. Global Nootropics Market for Sleep, Recovery, and Dream Enhancement, 2015 - 2024 (USD Million)
  • 5.7. Anxiety
    • 5.7.1. Global Nootropics Market for Anxiety, 2015 - 2024 (USD Million)

Chapter 6. Global Nootropics Market - Regional Analysis

  • 6.1. Global Nootropics Market: Regional Overview
    • 6.1.1. Global Nootropics Market Revenue Share, by Region, 2017 -2024
  • 6.2. North America
    • 6.2.1. North America Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.2.2. The U.S.
      • 6.2.2.1. The U.S. Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.2.3. Rest of North America
      • 6.2.3.1. Rest of North America Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.3.3. France
      • 6.3.3.1. France Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Germany Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.3.5. Rest of Europe
      • 6.3.5.1. Rest of Europe Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.4.5. Rest of Asia Pacific
      • 6.4.5.1. Rest of Asia Pacific Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
    • 6.5.3. Rest of Latin America
      • 6.5.3.1. Rest of Latin America Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)
  • 6.6. The Middle East and Africa
    • 6.6.1. The Middle East and Africa Nootropics Market Revenue, by Application, 2015 - 2024 (USD Million)

Chapter 7. Global Nootropics Market - Company Profile

  • 7.1. Accelerated Intelligence, Inc.
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Type portfolio
    • 7.1.4. Business strategy
    • 7.1.5. Recent developments
  • 7.2. Nootrobox, Inc.
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Type portfolio
    • 7.2.4. Business strategy
    • 7.2.5. Recent developments
  • 7.3. AlternaScript LLC
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Type portfolio
    • 7.3.4. Business strategy
    • 7.3.5. Recent developments
  • 7.4. Onnit Labs LLC
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Type portfolio
    • 7.4.4. Business strategy
    • 7.4.5. Recent developments
  • 7.5. Cephalon, Inc.
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Type portfolio
    • 7.5.4. Business strategy
    • 7.5.5. Recent developments
  • 7.6. Clarity Nootropics
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Type portfolio
    • 7.6.4. Business strategy
    • 7.6.5. Recent developments
  • 7.7. Peak Nootropics
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Type portfolio
    • 7.7.4. Business strategy
    • 7.7.5. Recent developments
  • 7.8. United Pharmacies
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Type portfolio
    • 7.8.4. Business strategy
    • 7.8.5. Recent developments
  • 7.9. Powder City LLC
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Type portfolio
    • 7.9.4. Business strategy
    • 7.9.5. Recent developments
  • 7.10. Purelife Bioscience Co., Ltd.
    • 7.10.1. Overview
    • 7.10.2. Financials
    • 7.10.3. Type portfolio
    • 7.10.4. Business strategy
    • 7.10.5. Recent developments
  • 7.11. SupNootropic Biological Technology Co., Ltd.
    • 7.11.1. Overview
    • 7.11.2. Financials
    • 7.11.3. Type portfolio
    • 7.11.4. Business strategy
    • 7.11.5. Recent developments